Immunodepletion of MDSC by AMV564, a novel bivalent, bispecific CD33/CD3 T cell engager, ex vivo in MDS and melanoma
AMV564（一种新型双价双特异性 CD33/CD3 T 细胞接合剂）在体外对 MDS 和黑色素瘤中的 MDSC 进行免疫耗竭
期刊:Molecular Therapy
影响因子:12.1
doi:10.1016/j.ymthe.2022.02.005
Pingyan Cheng, Xianghong Chen, Robert Dalton, Alexandra Calescibetta, Tina So, Danielle Gilvary, Grace Ward, Victoria Smith, Sterling Eckard, Judith A Fox, Jeanmarie Guenot, Joseph Markowitz, John L Cleveland, Kenneth L Wright, Alan F List, Sheng Wei, Erika A Eksioglu
